CYP8B1 and fatty liver disease: It has been reported that reducing the ratio of 12-OH/non-12-OH BAs by knockout of CYP8B1 could lead to the decrease in weight gain and improvement of glucose tolerance and hepatic steatosis in western diet-fed mice [49].